ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Baylor Recruits Scardino, Osborne, 13 Others; Likely To Gain Its Second NCI SPORE Grants

April 30, 1999

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

NCI, Dialogue Plan A National Tissue Bank

July 11, 2003

UICC Fellowship, Exchange Programs

July 5, 1985

New ESA Label Maintains 12 g/dL

November 9, 2007

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987